SEK 5.64
(-1.05%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 8.57 Million SEK | -18.35% |
2022 | 10.5 Million SEK | 1602.76% |
2021 | 617 Thousand SEK | -50.56% |
2020 | 1.24 Million SEK | 2300.0% |
2019 | 52 Thousand SEK | -80.95% |
2018 | 273 Thousand SEK | 0.0% |
2017 | - SEK | 0.0% |
2016 | - SEK | 0.0% |
2015 | - SEK | -100.0% |
2014 | 37 Thousand SEK | -66.67% |
2013 | 111 Thousand SEK | -40.0% |
2012 | 185 Thousand SEK | -17.23% |
2011 | 223.5 Thousand SEK | -91.73% |
2010 | 2.7 Million SEK | -8.66% |
2009 | 2.96 Million SEK | -19.55% |
2008 | 3.67 Million SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 8.57 Million SEK | 0.0% |
2024 Q2 | 20.82 Million SEK | 0.0% |
2023 FY | 8.57 Million SEK | -18.35% |
2023 Q4 | 8.57 Million SEK | -8.0% |
2023 Q1 | 9.83 Million SEK | -6.38% |
2023 Q2 | 9.9 Million SEK | 0.7% |
2023 Q3 | 9.32 Million SEK | -5.87% |
2022 Q3 | 11.75 Million SEK | 1662.07% |
2022 Q4 | 10.5 Million SEK | -10.61% |
2022 Q1 | 360 Thousand SEK | -41.65% |
2022 FY | 10.5 Million SEK | 1602.76% |
2022 Q2 | 667 Thousand SEK | 85.28% |
2021 FY | 617 Thousand SEK | -50.56% |
2021 Q2 | 680 Thousand SEK | -19.34% |
2021 Q1 | 843 Thousand SEK | -32.45% |
2021 Q3 | 740 Thousand SEK | 8.82% |
2021 Q4 | 617 Thousand SEK | -16.62% |
2020 Q2 | - SEK | 0.0% |
2020 Q1 | - SEK | -100.0% |
2020 FY | 1.24 Million SEK | 2300.0% |
2020 Q4 | 1.24 Million SEK | -20.91% |
2020 Q3 | 1.57 Million SEK | 0.0% |
2019 Q4 | 52 Thousand SEK | 0.0% |
2019 FY | 52 Thousand SEK | -80.95% |
2019 Q2 | - SEK | 0.0% |
2019 Q1 | - SEK | -100.0% |
2019 Q3 | - SEK | 0.0% |
2018 Q3 | - SEK | 0.0% |
2018 Q2 | - SEK | 0.0% |
2018 FY | 273 Thousand SEK | 0.0% |
2018 Q4 | 273 Thousand SEK | 0.0% |
2018 Q1 | - SEK | -100.0% |
2017 Q1 | - SEK | 0.0% |
2017 Q2 | - SEK | 0.0% |
2017 Q3 | - SEK | 0.0% |
2017 Q4 | 791 Thousand SEK | 0.0% |
2017 FY | - SEK | 0.0% |
2016 Q4 | - SEK | 0.0% |
2016 Q3 | - SEK | 0.0% |
2016 FY | - SEK | 0.0% |
2016 Q2 | - SEK | 0.0% |
2016 Q1 | - SEK | 0.0% |
2015 FY | - SEK | -100.0% |
2015 Q3 | - SEK | 0.0% |
2015 Q4 | - SEK | 0.0% |
2015 Q1 | - SEK | -100.0% |
2015 Q2 | - SEK | 0.0% |
2014 FY | 37 Thousand SEK | -66.67% |
2014 Q4 | 37 Thousand SEK | 37.04% |
2014 Q3 | 27 Thousand SEK | -63.51% |
2014 Q2 | 74 Thousand SEK | 0.0% |
2014 Q1 | - SEK | -100.0% |
2013 Q4 | 111 Thousand SEK | 0.0% |
2013 Q2 | 178 Thousand SEK | 0.0% |
2013 Q1 | 178 Thousand SEK | -3.78% |
2013 FY | 111 Thousand SEK | -40.0% |
2012 Q4 | 185 Thousand SEK | 0.0% |
2012 FY | 185 Thousand SEK | -17.23% |
2012 Q2 | 146.84 Thousand SEK | 0.0% |
2011 FY | 223.5 Thousand SEK | -91.73% |
2011 Q4 | 223.5 Thousand SEK | 0.0% |
2011 Q2 | 2.68 Million SEK | 0.0% |
2010 Q4 | 2.7 Million SEK | 0.0% |
2010 Q2 | 3.24 Million SEK | 0.0% |
2010 FY | 2.7 Million SEK | -8.66% |
2009 Q4 | 2.96 Million SEK | 0.0% |
2009 FY | 2.96 Million SEK | -19.55% |
2008 FY | 3.67 Million SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acarix AB (publ) | - SEK | -Infinity% |
ADDvise Group AB (publ) | 1.45 Billion SEK | 99.411% |
ADDvise Group AB (publ) | 1.45 Billion SEK | 99.411% |
Arcoma AB | 1.92 Million SEK | -345.148% |
Bactiguard Holding AB (publ) | 42.3 Million SEK | 79.724% |
BICO Group AB (publ) | 1.75 Billion SEK | 99.511% |
Boule Diagnostics AB (publ) | 57.7 Million SEK | 85.133% |
CellaVision AB (publ) | 28.66 Million SEK | 70.074% |
Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -3746.637% |
Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
C-Rad AB (publ) | 1.75 Million SEK | -389.333% |
Duearity AB (publ) | 2.94 Million SEK | -191.769% |
Dignitana AB (publ) | 6.07 Million SEK | -41.155% |
Episurf Medical AB (publ) | 2.3 Million SEK | -272.957% |
Getinge AB (publ) | 3.9 Billion SEK | 99.78% |
Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -35.025% |
Iconovo AB (publ) | 4.9 Million SEK | -74.815% |
Integrum AB (publ) | 4.84 Million SEK | -77.065% |
Luxbright AB (publ) | 206.02 Thousand SEK | -4063.593% |
Mentice AB (publ) | 2.14 Million SEK | -300.093% |
OssDsign AB (publ) | 214 Thousand SEK | -3908.411% |
Paxman AB (publ) | 2.53 Million SEK | -238.784% |
Promimic AB (publ) | - SEK | -Infinity% |
Qlife Holding AB (publ) | 3 Million SEK | -185.553% |
SciBase Holding AB (publ) | 4.17 Million SEK | -105.264% |
ScandiDos AB (publ) | - SEK | -Infinity% |
Sectra AB (publ) | 19.2 Million SEK | 55.332% |
Sedana Medical AB (publ) | 1.01 Million SEK | -747.628% |
SpectraCure AB (publ) | 4.39 Million SEK | -95.088% |
Stille AB | 38.06 Million SEK | 77.465% |
Vitrolife AB (publ) | 1.87 Billion SEK | 99.543% |
Xvivo Perfusion AB (publ) | 21.16 Million SEK | 59.478% |